Category icon
USC 21 Discussion: Optimal Antiplatelet Regimen in HBR

Mirvat Alasnag, Khaled Al-Shaibi, Roisin Colleran et al

Category icon
Antithrombotic Therapy in Complex PCI Patients Under OAC

Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos, et al

Category icon
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall

Category icon
Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin

Johny Nicolas, Usman Baber, Roxana Mehran,

Category icon
Antithrombotics in TAVR

Mathew R Williams, Kelsey Grossman, Homam Ibrahim,

Category icon
High-sensitivity Troponins - Difficult Friends in Acute Coronary Syndromes

Roland Klingenberg, Christian M Matter, Danielle Hof, et al

Category icon
Management of Chronic Coronary Disease and Acute Coronary Syndromes in…

Karthiek R Narala, Thomas A LaLonde, Sohail Hassan, et al

Category icon
Novel Oral Antiplatelet Agents

Suzanne J Baron, Robert P Giugliano,

Related Articles

Articles

Antithrombotic Therapy in Complex PCI Patients Under OAC

Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos,

Published:

Citation: US Cardiology Review 2021;15:e09.

Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin

Johny Nicolas, Usman Baber, Roxana Mehran,

Published:

Citation: US Cardiology Review 2020;14:e04.

Antithrombotics in TAVR

Mathew R Williams, Kelsey Grossman, Homam Ibrahim,

Published:

Citation: US Cardiology Review 2019;13(2):88–93.

Optimizing Crossover From Ticagrelor to Clopidogrel

Donald E Cutlip,

Citation: US Cardiology Review 2017;11(2):59–61.